Phibro Animal Health Corp
PAHC40.060USD
+0.190+0.48%
收盤 01/15, 16:00（美東）報價延遲15分鐘
1.62B總市值
23.94本益比TTM
關於 Phibro Animal Health Corp 公司
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Phibro Animal Health Corp簡介
公司代碼PAHC
公司名稱Phibro Animal Health Corp
上市日期Apr 11, 2014
CEOBendheim (Jack C)
員工數量2475
證券類型Ordinary Share
年結日Apr 11
公司地址Glenpointe Centre East, 3Rd Floor
城市TEANECK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編07666
電話12013297300
網址https://www.pahc.com/
公司代碼PAHC
上市日期Apr 11, 2014
CEOBendheim (Jack C)
Phibro Animal Health Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
收入明細
單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
地區USD
名稱
營收
佔比
United States
202.35M
55.61%
Latin America and Canada
87.23M
23.97%
Europe & Middle East & Africa
44.94M
12.35%
Asia Pacific
29.38M
8.07%
業務
地區
業務USD
名稱
營收
佔比
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
股東統計
更新時間: 11月18日 週二
更新時間: 11月18日 週二
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
其他
67.35%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
其他
67.35%
股東類型
持股股東
佔比
Investment Advisor
55.65%
Investment Advisor/Hedge Fund
29.60%
Hedge Fund
8.81%
Research Firm
3.30%
Pension Fund
1.72%
Individual Investor
0.52%
Bank and Trust
0.46%
Corporation
0.19%
Sovereign Wealth Fund
0.05%
機構持股
更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
421
20.39M
99.73%
-3.12M
2025Q3
390
21.83M
106.75%
-2.29M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
2.92M
14.28%
-23.05K
-0.78%
Sep 30, 2025
The Vanguard Group, Inc.
1.52M
7.44%
-22.54K
-1.46%
Sep 30, 2025
State Street Investment Management (US)
894.04K
4.37%
-15.29K
-1.68%
Sep 30, 2025
Acadian Asset Management LLC
785.82K
3.84%
+61.38K
+8.47%
Sep 30, 2025
Renaissance Technologies LLC
555.20K
2.72%
-55.60K
-9.10%
Sep 30, 2025
Geode Capital Management, L.L.C.
547.16K
2.68%
-7.77K
-1.40%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
485.51K
2.37%
-71.73K
-12.87%
Sep 30, 2025
Nuveen LLC
478.02K
2.34%
+19.45K
+4.24%
Sep 30, 2025
Fidelity Management & Research Company LLC
413.62K
2.02%
+354.02K
+594.03%
Sep 30, 2025
Castleknight Management LP
399.78K
1.96%
-131.56K
-24.76%
Sep 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
AAM Sawgrass US Small Cap Quality Growth ETF
2.49%
State Street SPDR S&P Pharmaceuticals ETF
1.19%
Innovator IBD 50 Fund ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
1.06%
Inspire Fidelis Multi Factor ETF
1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.02%
Lattice Hartford Multifactor Small Cap ETF
0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco NASDAQ Future Gen 200 ETF
0.61%
Invesco S&P SmallCap Health Care ETF
0.52%
查看更多
AAM Sawgrass US Small Cap Quality Growth ETF
佔比2.49%
State Street SPDR S&P Pharmaceuticals ETF
佔比1.19%
Innovator IBD 50 Fund ETF
佔比1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
佔比1.06%
Inspire Fidelis Multi Factor ETF
佔比1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比1.02%
Lattice Hartford Multifactor Small Cap ETF
佔比0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比0.76%
Invesco NASDAQ Future Gen 200 ETF
佔比0.61%
Invesco S&P SmallCap Health Care ETF
佔比0.52%
分紅派息
近5年累計派現
97.20M
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Nov 04, 2025
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 17, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 17, 2025
Nov 26, 2025
Jul 29, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 24, 2025 going ex on Sep 03, 2025
Sep 03, 2025
Sep 24, 2025
Sep 03, 2025
May 06, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 25, 2025 going ex on Jun 04, 2025
Jun 04, 2025
Jun 25, 2025
Jun 04, 2025
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
查看更多
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
常見問題
Phibro Animal Health Corp的前五大股東是誰？
Phibro Animal Health Corp的前五大股東如下：
BlackRock Institutional Trust Company, N.A.持有股份：2.92M佔總股份比例：14.28%。
The Vanguard Group, Inc.持有股份：1.52M佔總股份比例：7.44%。
State Street Investment Management (US)持有股份：894.04K佔總股份比例：4.37%。
Acadian Asset Management LLC持有股份：785.82K佔總股份比例：3.84%。
Renaissance Technologies LLC持有股份：555.20K佔總股份比例：2.72%。
BlackRock Institutional Trust Company, N.A.持有股份：2.92M佔總股份比例：14.28%。
The Vanguard Group, Inc.持有股份：1.52M佔總股份比例：7.44%。
State Street Investment Management (US)持有股份：894.04K佔總股份比例：4.37%。
Acadian Asset Management LLC持有股份：785.82K佔總股份比例：3.84%。
Renaissance Technologies LLC持有股份：555.20K佔總股份比例：2.72%。
Phibro Animal Health Corp的前三大股東類型是什麼？
Phibro Animal Health Corp 的前三大股東類型分別是：
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)
有多少機構持有Phibro Animal Health Corp(PAHC)的股份？
截至2025Q4，共有421家機構持有Phibro Animal Health Corp的股份，合計持有的股份價值約為20.39M，占公司總股份的99.73% 。與2025Q3相比，機構持股有所增加，增幅為-7.02%。
哪個業務部門對Phibro Animal Health Corp的收入貢獻最大？
在FY2026Q1，MFAs and Other業務部門對Phibro Animal Health Corp的收入貢獻最大，創收195.20M，占總收入的53.64% 。
